Tempus AI shares rise 5% pre-market on continued momentum, Ambry Genetics acquisition
Shares of Tempus AI , Inc. (NASDAQ:TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of ...
Yahoo Finance8d
Tempus Completes Acquisition of Ambry Genetics
Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. Tempus is a technology ...
Nature6y
Breaking new ground through high-quality genetic testing
Ambry Genetics drives innovation in diagnostics by launching cutting-edge genetic tests and technologies. Its broad collaborations, novel research projects, and networks for data sharing ...